Method of collecting placental stem cells
View Patent ↗A method of collecting embryonic-like stem cells from a placenta which has been treated to remove residual cord blood by perfusing the drained placenta with an anticoagulant solution to flush out residual cells, collecting the residual cells and perfusion liquid from the drained placenta, and separating the embryonic-like cells from the residual cells and perfusion liquid. Exogenous cells can be propagated in the placental bioreactor and bioactive molecules collected therefrom.
1. A method of collecting CD34 + stem cells from an isolated and exsanguinated mammalian placenta, said method comprising:
perfusing said placenta with a perfusion solution in an amount and for a time sufficient to collect a detectable amount of said cells comprising CD34 + stem cells, wherein said placenta has been drained of cord blood and flushed to remove residual blood prior to said perfusing, wherein said CD34 + stem cells are not obtained from cord blood, and wherein said perfusing is performed by passing said perfusion solution into one or both of the umbilical artery and umbilical vein of said placenta; and
collecting said CD34 + stem cells and perfusion solution from said placenta.
2. The method of claim 1 , wherein said perfusing is performed at at least four hours after removal of said residual blood.
3. The method of claim 1 , wherein said perfusing is performed at at least twelve hours after removal of said residual blood.
4. The method of claim 1 , wherein said perfusing is performed at at least 24 hours after removal of said residual blood.
5. The method of claim 1 , wherein said perfusing is performed using a first volume of between about 30 ml and about 150 ml of said perfusion solution.
6. The method of claim 5 , further comprising continuing said perfusing using a second volume of about 30 ml to about 150 ml of said perfusion solution, said second volume being collected separately from said first volume.
7. The method of claim 1 , in which said perfusing is performed for a plurality of times.
8. The method of claim 7 , wherein, for each of said times, said perfusing is performed using a volume of about 30 ml to about 150 ml of said perfusion solution.
9. The method of claim 1 , wherein said perfusion solution comprises an anticoagulant.
10. The method of claim 5 , wherein said perfusion solution comprises an anticoagulant.
11. The method of claim 7 , wherein said perfusion solution comprises an anticoagulant.
12. The method of claim 1 , wherein said perfusion solution comprises heparin, ethylene diamine tetra acetic acid (EDTA) or creatine phosphate dextrose (CPDA).
13. The method of claim 1 , wherein said perfusion solution comprises a growth factor or a cytokine.
14. The method of claim 13 , wherein said growth factor or cytokine is selected from the group consisting of a colony stimulating factor, interferon, erythropoietin, stem cell factor, thrombopoietin, an interleukin, granulocyte colony-stimulating factor, and any combination thereof.
15. The method of claim 1 , wherein said isolated mammalian placenta is a post-partum placenta remaining after a successful birth.
16. The method of claim 1 , further comprising separating said CD34 + stem cells from cells other than CD34 + stem cells and said perfusion solution.
17. The method of claim 5 , further comprising separating said CD34 + stem cells from said perfusion solution.
18. The method of claim 6 , further comprising separating said CD34 + stem cells from said perfusion solution.
19. The method of claim 5 , wherein said CD34 + stem cells are collected over a period of up to 48 hours.
20. The method of claim 6 , wherein said CD34 + stem cells are collected over a period of up to 48 hours.